Free Newsletter
Statins could be linked to Parkinson's disease
A new study at the University of North Carolina indicates that statins could be linked to an increase risk of Parkinson's disease. Statins lower the level of 'bad' LDL cholesterols, which in turn was found among Parkinson's patients. Critics of the study have contended that with only 124 Parkinson's patients taking part, there wasn't enough data to confirm the link. And the researchers say they intend to test the results in a trial involving 16,000 patients. Parkinson's is characterized by the absence of dopamine-producing cells, resulting in tremors, stiffness and poor coordination.
- here's the report on the statin research
Related Articles:
Stem cell transplant a success against Parkinson's. Report
Crestor less safe than competing statins. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: